| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 4 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | United States | 3 | |
| #4 | WIPO (World Intellectual Property Organization) | 3 | |
| #5 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Biotechnology | |
| #4 | Medical technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Organic chemistry methods | |
| #6 | Peptides | |
| #7 | Electrotherapy |
| # | Name | Total Patents |
|---|---|---|
| #1 | Barbosa Antonio J | 5 |
| #2 | Gupta Vineet | 5 |
| #3 | Slee Deborah Helen | 2 |
| #4 | Zhou Lei | 2 |
| #5 | Bhakta Nihar | 2 |
| #6 | Dupont Jakob | 2 |
| #7 | Peterson Caryn | 2 |
| #8 | Barbosa Antonio | 1 |
| #9 | Bruey Jean-Marie | 1 |
| #10 | Coburn Craig Alan | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021061665A1 | Integrin agonist prodrugs | |
| WO2020236668A1 | Leukadherin-1 alone or in combination for use in the treatment of cancer | |
| US2020123146A1 | Heterocyclic integrin agonists |